A promising theory stumbles in clinical trials.
Morrow
Thomas
T
Genentech, Inc., USA.
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D002986:Clinical Trials as Topic; D006801:Humans; D008962:Models, Theoretical; D009203:Myocardial Infarction / Q000276:immunology*; D011486:Protein C; D057127:Single-Chain Antibodies; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D011486:Protein C; D057127:Single-Chain Antibodies; C402724:pexelizumab